6.4.2 Gap Analysis 88 6.4.3 Opportunity 89 6.5 Simplified Dosing 90 6.5.1 Unmet Need 90 6.5.2 Gap Analysis 91 6.5.3 Opportunity 92 6.6 Patient Education to Improve Tolerance and Compliance 92 6.6.1 Unmet Need 92 6.6.2 Gap Analysis 94 6.6.3 Opportunity 95
Browse Complete Summary Click Here @ http :// www . radiantinsights . com / research / dry-eyesyndrome-china-drug-forecast-and-market-analysis-to-2024
6.7 Improved Physician and Patient Disease Awareness 95 6.7.1 Unmet Need 95 6.7.2 Gap Analysis 97 6.7.3 Opportunity 97
7 Pipeline Assessment 98 7.1 Overview 98 7.2 Clinical Trial Mapping 99 7.2.1 Clinical Trial Design for DES 100 7.2.2 Ora for DES Drug Development 101 7.3 Promising Drugs in Clinical Development 102 7.3.1 Lifitegrast 104 7.3.2 Tavilermide 113 7.3.3 Visomitin 119